Diphtheria
📧 Sign up to get email alerts when something new happens for Diphtheria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of DTaP-IPV vaccine as a booster in healthy children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Hepatitis B Vaccination in Infants [Phase 4]
A Phase 4 clinical trial update on Hepatitis B vaccination in infants has completed, with sponsor Public Health England evaluating vaccinati…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in healthy sub…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines [Phase 3]
Phase 3 trial comparing three lots of GSK DTaP-IPV candidate vaccine to DTaP + IPV vaccines; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of GC3111 in healthy adults for tetanus, diphtheria, and pertussis. Status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a booster dose of Infanrix Hexa in healthy infants born to mothers vaccinated with Boo…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). [Phase 3]
Phase 3 immunogenicity and safety trial evaluating combined or separate vaccines against common childhood diseases in infants (2, 4, 6 month…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects [Phase 3]
Phase 3 trial evaluating immunogenicity, safety, and reactogenicity of Boostrix booster in healthy Russian adults completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Post-marketing, observational study assessing safety of Refortrix (Tdap) administered during pregnancy in Brazil; completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants [Phase 2]
Phase 2 study assessing safety and immunogenicity of a hexavalent DTwP-HepB-IPV-Hib vaccine in healthy infants; status not specified.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: A Phase IV Study to Assess the Safety of EupentaTM Inj [Phase 4]
Phase IV study update assessing the safety of EupentaTM Inj; the document lists multiple conditions and an unknown status for the trial.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia [Phase 3]
Phase 3 trial assessing immunogenicity and safety of Infanrix-IPV/Hib given in a three-dose schedule with a booster in healthy infants in Ru…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 immunogenicity and safety study of Infanrix Hexa in healthy infants, including those born to mothers vaccinated during pregnancy or …
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia [Phase 4]
Phase 4 trial update evaluating the immunogenicity of a single Boostrix dose in infants prior to primary pertussis vaccination when administ…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women [Phase 4]
Phase 4 trial assessing immunogenicity and safety of Boostrix vaccine in pregnant women has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058 [Phase 4]
A Phase 4 clinical trial update evaluating immunogenicity and reactogenicity of Boostrix ten years after prior booster vaccination.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants [Phase 3]
Phase 3 clinical trial update on the immunogenicity, safety and reactogenicity of the combined DTPa-IPV vaccine in healthy infants; results …
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults [Phase 3]
Phase 3 trial assessing immunogenicity and safety of coadministering GSK Tdap vaccine Boostrix with GSK influenza vaccine Fluarix in adults.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m [Phase 3]
Phase 3 trial update of Tritanrix-HepB/Hib-MenAC and Mencevax ACWY vaccines with completed status and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]
Phase 3 safety trial update for a meningitis vaccine in infants following birth dose of Hepatitis B, completed.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]
Phase 3 safety study evaluating a vaccine against meningitis in infants following a birth dose of hepatitis B; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents [Phase 4]
A Phase 4 trial assessing immunogenicity and safety of Boostrix using a new syringe in adolescents aged 10 to 15 years; results completed an…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years [Phase 3]
Phase 3 trial assessing safety and immunogenicity of GSK Boostrix (Tdap) in adults 19–64; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 trial assessing immunogenicity and safety of GSK Infanrix Hexa given at 2, 4, and 6 months in healthy infants; study completed wit…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine [Phase 4]
Phase 4 trial assessed immunogenicity and safety of a tetanus-diphtheria vaccine given with a 13-valent pneumococcal conjugate vaccine; the …